Jennifer Lyn Herron serves as Executive at ARIAD PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Jennifer Lyn Herron has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 20, 2022 involved selling 17,237 shares valued at $0.
Jennifer Lyn Herron currently holds 17,237 shares of ARIAD PHARMACEUTICALS INC (ARIA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Lyn Herron has been a net neutral trader of ARIA stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Lyn Herron's most recent insider trade was on Oct 20, 2022, when they sold 17,237 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 16, 2017 | ARIA | $0 | Disposition | 450 | $N/A | Discretionary |